Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT01890265 · COMPLETED
Trial details
- NCT number
- NCT01890265
- Sponsor
- Kyntra Bio
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-30
- Primary completion
- 2017-11-16
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.